Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × marizomib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Glioma 2 Brain Neoplasms 2 Recurrence 1 Neoplasms 1 Gliosarcoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 18 Bevacizumab 13 Irinotecan 12 Carboplatin 9 Radiosurgery 8 Cyclophosphamide 8 Radiotherapy 7 Lomustine 7 pembrolizumab 6 Vincristine 5 Topotecan 5 Surgical Procedures, Operative 5 Drug Therapy 5 Cisplatin 5 3-Iodobenzylguanidine 5 Metformin 4 Gemcitabine 4 Etoposide 4 Doxorubicin 4 Dexamethasone 4 trametinib 3 poly ICLC 3 Trastuzumab 3 Therapeutics 3 Radiation 3 Paclitaxel 3 Observation 3 Magnetic Resonance Imaging 3 Lapatinib 3 Cancer Vaccines 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04341311 2024-02-15

DIPG

Dana-Farber Cancer Institute

Phase 1 Terminated

Diffuse Intrinsic Pontine Glioma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡